Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase

Archives of Biochemistry and Biophysics

Volumn 461, Issue 1, 2007, Pages 76-84

  Li, Li ^a   Porter, Todd D ^a  

^a University of Kentucky   (United States)

Author keywords

Cholesterol synthesis; HMG CoA reductase; Lanosterol; Supernatant protein factor

Indexed keywords

ANTIBODY; CYTOCHROME P450 REDUCTASE; DIHYDROLANOSTEROL; SQUALENE MONOOXYGENASE; STEROL 14ALPHA DEMETHYLASE;

ANIMAL CELL; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MOUSE; LIPID STORAGE; LIVER CELL; LIVER MICROSOME; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

ANIMALS; CELL-FREE SYSTEM; CELLS, CULTURED; CYTOCHROMES B5; MICE; MICE, KNOCKOUT; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; SIGNAL TRANSDUCTION; SQUALENE MONOOXYGENASE;

MUS;

EID: 34247270767     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2007.02.010     Document Type: Article

References (32)

1. Sakakibara J., Watanabe R., Kanai Y., and Ono T. Molecular cloning and expression of rat squalene epoxidase. J. Biol. Chem. 270 (1995) 17-20
2. Yamamoto S., and Bloch K. Studies on squalene epoxidase of rat liver. J. Biol. Chem. 245 (1970) 1670-1674
3. Ono T., Takahashi K., Odani S., Konno H., and Imai Y. Purification of squalene epoxidase from rat liver microsomes. Biochem. Biophys. Res. Commun. 96 (1980) 522-528
4. Tai H.H., and Bloch K. Squalene epoxidase of rat liver. J. Biol. Chem. 247 (1972) 3767-3773
5. Ono T., and Bloch K. Solubilization and partial characterization of rat liver squalene epoxidase. J. Biol. Chem. 250 (1975) 1571-1579
6. Risley J.M. Cholesterol biosynthesis: Lanosterol to cholesterol. J. Chem. Educ. 79 (2002) 377-384
7. Nishino H., and Ishibashi T. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system. Arch. Biochem. Biophys. 374 (2000) 293-298
8. Lamb D.C., Kelly D.E., Manning N.J., Kaderbhai M.A., and Kelly S.L. Biodiversity of the P450 catalytic cycle: yeast cytochrome b5/NADH cytochrome b5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction. FEBS Lett. 462 (1999) 283-288
9. Shen A.L., O'Leary K.A., and Kasper C.B. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem. 277 (2002) 6536-6541
10. Otto D.M., Henderson C.J., Carrie D., Davey M., Gundersen T.E., Blomhoff R., Adams R.H., Tickle C., and Wolf C.R. Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol. Cell Biol. 23 (2003) 6103-6116
11. Gu J., Weng Y., Zhang Q.Y., Cui H., Behr M., Wu L., Yang W., Zhang L., and Ding X. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J. Biol. Chem. 278 (2003) 25895-25901
12. Henderson C.J., Otto D.M., Carrie D., Magnuson M.A., McLaren A.W., Rosewell I., and Wolf C.R. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem. 278 (2003) 13480-13486
13. Postic C., Shiota M., Niswender K.D., Jetton T.L., Chen Y., Moates J.M., Shelton K.D., Lindner J., Cherrington A.D., and Magnuson M.A. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274 (1999) 305-315
14. Wu L., Gu J., Weng Y., Kluetzman K., Swiatek P., Behr M., Zhang Q.Y., Zhuo X., Xie Q., and Ding X. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene. Genesis 36 (2003) 177-181
15. Singh D.K., Mokashi V., Elmore C.L., and Porter T.D. Phosphorylation of supernatant protein factor enhances its ability to stimulate microsomal squalene monooxygenase. J. Biol. Chem. 278 (2003) 5646-5651
16. Sutter T.R., and Loper J.C. Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole. Biochem. Biophys. Res. Commun. 160 (1989) 1257-1266
17. Ferguson J.B., and Bloch K. Purification and properties of a soluble protein activator of rat liver squalene epoxidase. J. Biol. Chem. 252 (1977) 5381-5385
18. Mokashi V., Singh D.K., and Porter T.D. Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro. Arch. Biochem. Biophys. 433 (2005) 474-480
19. Stocker A., Tomizaki T., Schulze-Briese C., and Baumann U. Crystal structure of the human supernatant protein factor. Structure (Camb) 10 (2002) 1533-1540
20. Bae S.H., and Paik Y.K. Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase. Biochem. J. 326 Pt 2 (1997) 609-616
21. Frye L.L., and Leonard D.A. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis. Crit. Rev. Biochem. Mol. Biol. 34 (1999) 123-140
22. Wang X.J., Chamberlain M., Vassieva O., Henderson C.J., and Wolf C.R. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice. Biochem. J. 388 (2005) 857-867
23. Weng Y., DiRusso C.C., Reilly A.A., Black P.N., and Ding X. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype. J. Biol. Chem. 280 (2005) 31686-31698
24. Ono T., Ozasa S., Hasegawa F., and Imai Y. Involvement of NADPH-cytochrome c reductase in the rat liver squalene epoxidase system. Biochim. Biophys. Acta 486 (1977) 401-407
25. Friedlander E.J., Caras I.W., Lin L.F., and Bloch K. Supernatant protein factor facilitates intermembrane transfer of squalene. J. Biol. Chem. 255 (1980) 8042-8045
26. Porter T.D. Supernatant protein factor and tocopherol-associated protein: An unexpected link between cholesterol synthesis and vitamin E. J. Nutr. Biochem. 14 (2003) 3-6
27. Panagabko C., Morley S., Hernandez M., Cassolato P., Gordon H., Parsons R., Manor D., and Atkinson J. Ligand specificity in the CRAL-TRIO protein family. Biochemistry 42 (2003) 6467-6474
28. Habermehl D., Kempna P., Azzi A., and Zingg J.M. Recombinant SEC14-like proteins (TAP) possess GTPase activity. Biochem. Biophys. Res. Commun. 326 (2005) 254-259
29. Kempna P., Zingg J.M., Ricciarelli R., Hierl M., Saxena S., and Azzi A. Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic. Biol. Med. 34 (2003) 1458-1472
30. Ni J., Wen X., Yao J., Chang H.C., Yin Y., Zhang M., Xie S., Chen M., Simons B., Chang P., di Sant'Agnese A., Messing E.M., and Yeh S. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res. 65 (2005) 9807-9816
31. Mokashi V., and Porter T.D. Supernatant protein factor requires phosphorylation and interaction with Golgi to stimulate cholesterol synthesis in hepatoma cells. Arch. Biochem. Biophys. 435 (2005) 175-181
32. Song B.L., Javitt N.B., and DeBose-Boyd R.A. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 1 (2005) 179-189